IL18 and Parkinson disease: The most prominent PPI hotspot identified by Henderson, A.R., et al. [46] in their analysis was the IL18/IL18R1 pathway, which clearly demonstrated the up-regulatory effect of hypomethylation on IL18/IL18R1 expression and highlighted the contribution of IL18 to the neuroinflammatory process in PD.